190 related articles for article (PubMed ID: 31527554)
1. Single Cell Mass Cytometry of Non-Small Cell Lung Cancer Cells Reveals Complexity of In vivo And Three-Dimensional Models over the Petri-dish.
Alföldi R; Balog JÁ; Faragó N; Halmai M; Kotogány E; Neuperger P; Nagy LI; Fehér LZ; Szebeni GJ; Puskás LG
Cells; 2019 Sep; 8(9):. PubMed ID: 31527554
[TBL] [Abstract][Full Text] [Related]
2. Analysis of the Single-Cell Heterogeneity of Adenocarcinoma Cell Lines and the Investigation of Intratumor Heterogeneity Reveals the Expression of Transmembrane Protein 45A (TMEM45A) in Lung Adenocarcinoma Cancer Patients.
Neuperger P; Balog JÁ; Tiszlavicz L; Furák J; Gémes N; Kotogány E; Szalontai K; Puskás LG; Szebeni GJ
Cancers (Basel); 2021 Dec; 14(1):. PubMed ID: 35008313
[TBL] [Abstract][Full Text] [Related]
3. [Non-small cell lung cancer 95D cells co-cultured with 3D-bioprinted scaffold to construct a lung cancer model in vitro].
Mou H; Wang J; Hu H; Xu W; Chen Q
Zhonghua Zhong Liu Za Zhi; 2015 Oct; 37(10):736-40. PubMed ID: 26813591
[TBL] [Abstract][Full Text] [Related]
4. Development of an innovative 3D cell culture system to study tumour--stroma interactions in non-small cell lung cancer cells.
Amann A; Zwierzina M; Gamerith G; Bitsche M; Huber JM; Vogel GF; Blumer M; Koeck S; Pechriggl EJ; Kelm JM; Hilbe W; Zwierzina H
PLoS One; 2014; 9(3):e92511. PubMed ID: 24663399
[TBL] [Abstract][Full Text] [Related]
5. Culturing substrates influence the morphological, mechanical and biochemical features of lung adenocarcinoma cells cultured in 2D or 3D.
Prina-Mello A; Jain N; Liu B; Kilpatrick JI; Tutty MA; Bell AP; Jarvis SP; Volkov Y; Movia D
Tissue Cell; 2018 Feb; 50():15-30. PubMed ID: 29429514
[TBL] [Abstract][Full Text] [Related]
6. Gene expression profile of A549 cells from tissue of 4D model predicts poor prognosis in lung cancer patients.
Mishra DK; Creighton CJ; Zhang Y; Gibbons DL; Kurie JM; Kim MP
Int J Cancer; 2014 Feb; 134(4):789-98. PubMed ID: 23934967
[TBL] [Abstract][Full Text] [Related]
7. Mimicking Tumor Hypoxia in Non-Small Cell Lung Cancer Employing Three-Dimensional In Vitro Models.
Ziółkowska-Suchanek I
Cells; 2021 Jan; 10(1):. PubMed ID: 33445709
[TBL] [Abstract][Full Text] [Related]
8. Antiproliferative and antimetastatic characterization of an exo-heterocyclic androstane derivative against human breast cancer cell lines.
Kulmány ÁE; Frank É; Kovács D; Kirisits K; Krupitza G; Neuperger P; Alföldi R; Puskás LG; Szebeni GJ; Zupkó I
Biomed Pharmacother; 2021 Aug; 140():111728. PubMed ID: 34020244
[TBL] [Abstract][Full Text] [Related]
9. The role of CD133 in the identification and characterisation of tumour-initiating cells in non-small-cell lung cancer.
Tirino V; Camerlingo R; Franco R; Malanga D; La Rocca A; Viglietto G; Rocco G; Pirozzi G
Eur J Cardiothorac Surg; 2009 Sep; 36(3):446-53. PubMed ID: 19464919
[TBL] [Abstract][Full Text] [Related]
10. Assessment of the clinical relevance of 17q25.3 copy number and three-dimensional telomere organization in non-small lung cancer patients.
Sunpaweravong P; Thu KL; Lam WL; Mai S
J Cancer Res Clin Oncol; 2016 Apr; 142(4):749-56. PubMed ID: 26621152
[TBL] [Abstract][Full Text] [Related]
11. FGF1 and IGF1-conditioned 3D culture system promoted the amplification and cancer stemness of lung cancer cells.
Liu P; Zhang R; Yu W; Ye Y; Cheng Y; Han L; Dong L; Chen Y; Wei X; Yu J
Biomaterials; 2017 Dec; 149():63-76. PubMed ID: 29017078
[TBL] [Abstract][Full Text] [Related]
12. EZH2 inhibitors reverse resistance to gefitinib in primary EGFR wild-type lung cancer cells.
Gong H; Li Y; Yuan Y; Li W; Zhang H; Zhang Z; Shi R; Liu M; Liu C; Chen C; Liu H; Chen J
BMC Cancer; 2020 Dec; 20(1):1189. PubMed ID: 33276757
[TBL] [Abstract][Full Text] [Related]
13. Aldolase A promotes proliferation and G
Fu H; Gao H; Qi X; Zhao L; Wu D; Bai Y; Li H; Liu X; Hu J; Shao S
Cancer Commun (Lond); 2018 May; 38(1):18. PubMed ID: 29764507
[TBL] [Abstract][Full Text] [Related]
14. Three-dimensional lung tumor microenvironment modulates therapeutic compound responsiveness in vitro--implication for drug development.
Ekert JE; Johnson K; Strake B; Pardinas J; Jarantow S; Perkinson R; Colter DC
PLoS One; 2014; 9(3):e92248. PubMed ID: 24638075
[TBL] [Abstract][Full Text] [Related]
15. Non-malignant respiratory epithelial cells preferentially proliferate from resected non-small cell lung cancer specimens cultured under conditionally reprogrammed conditions.
Gao B; Huang C; Kernstine K; Pelekanou V; Kluger Y; Jiang T; Peters-Hall JR; Coquelin M; Girard L; Zhang W; Huffman K; Oliver D; Kinose F; Haura E; Teer JK; Rix U; Le AT; Aisner DL; Varella-Garcia M; Doebele RC; Covington KR; Hampton OA; Doddapaneni HV; Jayaseelan JC; Hu J; Wheeler DA; Shay JW; Rimm DL; Gazdar A; Minna JD
Oncotarget; 2017 Feb; 8(7):11114-11126. PubMed ID: 28052041
[TBL] [Abstract][Full Text] [Related]
16. ILT4 inhibition prevents TAM- and dysfunctional T cell-mediated immunosuppression and enhances the efficacy of anti-PD-L1 therapy in NSCLC with EGFR activation.
Chen X; Gao A; Zhang F; Yang Z; Wang S; Fang Y; Li J; Wang J; Shi W; Wang L; Zheng Y; Sun Y
Theranostics; 2021; 11(7):3392-3416. PubMed ID: 33537094
[No Abstract] [Full Text] [Related]
17. TP53 drives abscopal effect by secretion of senescence-associated molecular signals in non-small cell lung cancer.
Tesei A; Arienti C; Bossi G; Santi S; De Santis I; Bevilacqua A; Zanoni M; Pignatta S; Cortesi M; Zamagni A; Storci G; Bonafè M; Sarnelli A; Romeo A; Cavallo C; Bartolazzi A; Rossi S; Soriani A; Strigari L
J Exp Clin Cancer Res; 2021 Mar; 40(1):89. PubMed ID: 33673859
[TBL] [Abstract][Full Text] [Related]
18. 3D printing novel in vitro cancer cell culture model systems for lung cancer stem cell study.
Herreros-Pomares A; Zhou X; Calabuig-Fariñas S; Lee SJ; Torres S; Esworthy T; Hann SY; Jantus-Lewintre E; Camps C; Zhang LG
Mater Sci Eng C Mater Biol Appl; 2021 Mar; 122():111914. PubMed ID: 33641907
[TBL] [Abstract][Full Text] [Related]
19. CD151 drives cancer progression depending on integrin α3β1 through EGFR signaling in non-small cell lung cancer.
Zhu J; Cai T; Zhou J; Du W; Zeng Y; Liu T; Fu Y; Li Y; Qian Q; Yang XH; Li Q; Huang JA; Liu Z
J Exp Clin Cancer Res; 2021 Jun; 40(1):192. PubMed ID: 34108040
[TBL] [Abstract][Full Text] [Related]
20. High-affinity peptide ligand LXY30 for targeting α3β1 integrin in non-small cell lung cancer.
Xiao W; Ma W; Wei S; Li Q; Liu R; Carney RP; Yang K; Lee J; Nyugen A; Yoneda KY; Lam KS; Li T
J Hematol Oncol; 2019 Jun; 12(1):56. PubMed ID: 31182116
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
